Patents by Inventor Christian Lerche

Christian Lerche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dual drug pen-injection device with micro-reservoirs carrying secondary drug for emergency injection
    Patent number: 9272093
    Abstract: An injection device to deliver at least two medicaments is disclosed where a first medicament is delivered in settable doses with a first medicament dose delivery mechanism and a second medicament is delivered from micro-reservoirs upon activation of a second medicament delivery system, whereby activation of the second medicament delivery system locks out the first medicament dose delivery mechanism.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: March 1, 2016
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Amit Kohli, Christian Lerche
  • Dual Drug Pen-Injection Device with Micro-Reservoirs Carrying Secondary Drug For Emergency Injection
    Publication number: 20130324920
    Abstract: An injection device to deliver at least two medicaments is disclosed where a first medicament is delivered in settable doses with a first medicament dose delivery mechanism and a second medicament is delivered from micro-reservoirs upon activation of a second medicament delivery system, whereby activation of the second medicament delivery system locks out the first medicament dose delivery mechanism.
    Type: Application
    Filed: February 8, 2012
    Publication date: December 5, 2013
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Amit Kohli, Christian Lerche
  • Nucleic acid molecule encoding the potassium channel protein, KCNQ5
    Patent number: 6617131
    Abstract: KCNQ5, DNA encoding KCNQ5 or a polypeptide having KCNQ5 activity, related vectors, host cells and methods and a screening assay for identification of compounds which modify activity of a potassium channel KCNQ5 are described.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: September 9, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Klaus Steinmeyer, Christian Lerche, Constanze Scherer, Guiscard Seebohm, Andreas E. Busch
  • Potassium channel protein KCNQ5, a new target for diseases of central nervous system and cardiovascular system
    Publication number: 20020076809
    Abstract: KCNQ5, DNA encoding KCNQ5 or a polypeptide having KCNQ5 activity, related vectors, host cells and methods and a screening assay for identification of compounds which modify activity of a potassium channel KCNQ5 are described.
    Type: Application
    Filed: March 21, 2001
    Publication date: June 20, 2002
    Inventors: Klaus Steinmeyer, Christian Lerche, Constanze Scherer, Guiscard Seebohm, Andreas E. Busch